IsmailAGonalvesBLde NeeffDVPonzilacquaBCoppaCFSCHintzscheHet al
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
Examination of bacterial contamination at the time of embryo transfer, and its impact on the IVF/pregnancy outcome
Moreover, rapid testing methods are becoming increasingly available, allowing for quicker diagnosis and treatment initiation, which can significantly improve patient outcomes
Our article on myths about stem cell therapy explains what is often misunderstood and how clinical practice addresses these concerns
News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004